[NLSP] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[NLSP] NLS Pharmaceutics AG
Announcement Date
30-Dec-2018
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -50.00%
YoY-
Quarter Report
NLSP's Result
NLSP's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 -
PBT -4,559 -7,855 -7,343 -1,629 -2,032 -3 332.51%
Tax -0 -0 0 0 -2 -1 -
NP -4,559 -7,855 -7,343 -1,629 -2,032 -3 332.51%
Tax Rate - - - - - - -
Total Cost 4,559 7,855 7,343 1,629 2,032 3 332.51%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.14 -0.29 -0.50 -0.34 -0.18 -0.48 -21.83%
EPS Diluted -0.14 -0.29 -0.50 -0.34 -0.18 -0.48 -21.83%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.